Novo Nordisk Levemir Data Shows Weight Loss Advantage Over Sanofi’s Lantus
This article was originally published in The Pink Sheet Daily
Executive Summary
Studies show patients switched to Levemir from Lantus lost weight while improving glycemic control over 26-week period.